Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $96.00, but opened at $101.43. Sandoz Group shares last traded at $101.29, with a volume of 1,295 shares traded.
Analyst Ratings Changes
Separately, Erste Group Bank raised Sandoz Group to a “strong-buy” rating in a report on Thursday, August 27th. Four equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.
Get Our Latest Report on Sandoz Group
Sandoz Group Trading Down 0.5%
The firm’s 50-day simple moving average is $87.55 and its two-hundred day simple moving average is $83.98.
Sandoz Group Company Profile
Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.
Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.
Recommended Stories
- Five stocks we like better than Sandoz Group
- Breaching the Valuation: The Real Reason Fortinet Dropped
- Microsoft Earnings Expose a Growing Divide in the Magnificent 7 AI Trade
- Silicon Shock: Intel’s 25% Valuation Reset
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
